Form 4: CEL-SCI CFO Acquires Shares Under 10b5-1 Plan

CEL-SCI Corporation's Chief Financial Officer, Patricia B. Prichep, acquired 466 shares of common stock at $9.20 per share on September 30, 2025, increasing her direct beneficial ownership to 11,213 shares under a Rule 10b5-1 plan.

Summary

• Patricia B. Prichep, Chief Financial Officer of CEL-SCI Corp (CVM), acquired 466 shares of the company's common stock.
• The transaction occurred on September 30, 2025, at a price of $9.20 per share.
• Following this acquisition, Ms. Prichep directly beneficially owns 11,213 shares of CEL-SCI common stock.
• The acquisition was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive like the CFO, even if part of a 10b5-1 plan, generally signals confidence in the company's long-term prospects. The moderate volume of shares acquired contributes to a positive, but not overwhelmingly strong, sentiment score.

Positives

• Chief Financial Officer Patricia B. Prichep acquired 466 shares of common stock, which generally indicates management's continued commitment to the company.
• The acquisition increases her direct beneficial ownership to 11,213 shares, aligning her interests further with shareholders.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may interpret the CFO's share acquisition as a positive indicator, potentially bolstering investor confidence in the company's leadership and future direction.
• Employees might perceive this as a sign of stability and belief in the company's strategic path from its executive management.

Key Dates

Recommendation

The acquisition of shares by the CFO is a positive signal of management confidence. However, as this transaction was made pursuant to a Rule 10b5-1 plan, it reflects a pre-scheduled purchase rather than a new, opportunistic investment decision based on immediate market conditions. While it doesn't suggest a negative outlook, it also doesn't provide a strong enough signal for an immediate 'buy' recommendation without further fundamental analysis of CEL-SCI's broader financial health and strategic initiatives. A 'hold' recommendation is appropriate, acknowledging the positive insider action while awaiting more comprehensive data.

Keywords

CEL-SCI Corp, CVM, Insider Trading, Form 4, Patricia B. Prichep, CFO, Stock Acquisition, Rule 10b5-1